Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle L Hermiston

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Transplantation and Cellular Therapy|April 17, 2024
Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric ProtocolsGabriel Salinas Cisneros, Christopher C Dvorak, Janel Long-Boyle, et al.
British Journal of Haematology|April 18, 2022
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemiaLauren K Meyer, Cristina Delgado-Martin, Phillip P Sharp, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
The Journal of Clinical Investigation|November 6, 2019
Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytesLauren K Meyer, Benjamin J Huang, Cristina Delgado-Martin, et al.
Scientific Reports|January 27, 2026
Overweight & obesity epidemic, temporal trends and regional disparities in physical growth of Vietnamese childrenNhan Thi Ho, David Bangsberg, Michelle L Hermiston, et al.
Blood Advances|January 1, 2024
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group studyBirte Wistinghausen, Keri Toner, Donald A Barkauskas, et al.
Blood|January 29, 2021
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A Marsh, Adi Zoref-Lorenz, et al.
Blood|March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adultsGaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
Haematologica|October 20, 2022
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemiaAlan S Wayne, Van Huynh, Nobuko Hijiya, et al.
Blood|February 4, 2015
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemiaShannon L Maude, Sibasish Dolai, Cristina Delgado-Martin, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Transplantation and Cellular Therapy|April 17, 2024
Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric ProtocolsGabriel Salinas Cisneros, Christopher C Dvorak, Janel Long-Boyle, et al.
British Journal of Haematology|April 18, 2022
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemiaLauren K Meyer, Cristina Delgado-Martin, Phillip P Sharp, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
The Journal of Clinical Investigation|November 6, 2019
Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytesLauren K Meyer, Benjamin J Huang, Cristina Delgado-Martin, et al.
Scientific Reports|January 27, 2026
Overweight & obesity epidemic, temporal trends and regional disparities in physical growth of Vietnamese childrenNhan Thi Ho, David Bangsberg, Michelle L Hermiston, et al.
Blood Advances|January 1, 2024
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group studyBirte Wistinghausen, Keri Toner, Donald A Barkauskas, et al.
Blood|January 29, 2021
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A Marsh, Adi Zoref-Lorenz, et al.
Blood|March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adultsGaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
Haematologica|October 20, 2022
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemiaAlan S Wayne, Van Huynh, Nobuko Hijiya, et al.
Blood|February 4, 2015
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemiaShannon L Maude, Sibasish Dolai, Cristina Delgado-Martin, et al.
Pageof 6